IP Verse

Further Novel Forms Of Interfering Rna Molecules

PatentPatent Analysis

EP1857547

ATUGEN
Application Number
EP06027129A
Filing Date
Aug 5, 2003
Status
Patent Maintained As Amended
Oct 30, 2020
Grant Date
Dec 2, 2020
External Links
Slate, Register, Google Patents

Bibliography

The patent EP1857547B2 was granted to Atugen on Dec 2, 2020 following the initial filing on Aug 5, 2003 under the application number EP06027129A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

SANOFIOct 17, 2018WITHDRAWN
THE MEDICINES UKOct 16, 2018WITHDRAWN
ALNYLAM PHARMACEUTICALSAug 17, 2018WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents